Nigerian company begins producing diagnostics for major diseases
Summary and headline written by AI from the source article. How we work
Ash Biomedical Diagnostics Ltd. a Nigerian company, now manufactures seven diagnostic medicines to test for and manage HIV, malaria, hepatitis, and pregnancy.
The company’s products, including ABD HIVChek, MalChek, and PregSure, cover 12 different testing types within those four healthcare areas and are available nationwide in Nigeria. Adetoyese Shodeinde, the managing director, said this production reflects years of investment in quality control and regulatory compliance.
The new products include FlaviQuik, a rapid test for Hepatitis C, and HepaQuik Duo, which screens for both Hepatitis B and C with a single test. Shodeinde explained that these additions would help healthcare providers identify patients needing further evaluation more efficiently. He also emphasized the importance of locally developed healthcare solutions for increasing confidence in Nigeria’s medical capabilities and improving access to testing.
Since its founding in 2011, Ash Biomedical has provided 15 million test kits through contracts with government and institutions in 27 Nigerian states, reaching all 36 states total. Evaluations by several hospitals, including APIN Reference Laboratory and National Hospital, Abuja, confirmed that Ash Biomedical’s rapid tests accurately matched results from standard laboratory findings. The company is currently building a new manufacturing facility in Idu, Abuja, expected to be completed by the first quarter of 2027.
